Japan Cancer Treatment

• Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  ... GlobalData’s “Japan Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More

• Japan Platinum Based Cancer Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  Apr 18, 2023  |  Published by: Infinium Global Research  |  USD 2,595

  ... the Japan market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the platinum based cancer drug ... Read More

• 2023 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

  Mar 16, 2023  |  Published by: VPGMarketResearch.com  |  USD 19,500

  ... Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The ... Read More

• 2023 Global Molecular Diagnostics Market in the US, Europe, Japan - 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

  Jan 23, 2023  |  Published by: VPGMarketResearch.com  |  USD 14,500

  ... Tests This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies ... Read More

• MEA Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030

  Jan 01, 2023  |  Published by: Data Bridge Market Research  |  USD 3,500

  ... Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and ... Read More

• Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; and Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others) - Japan Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

  Apr 22, 2022  |  Published by: Transparency Market Research Pvt. Ltd.  |  USD 5,795

  ... and Forecast, 2021-2031 Japan Direct-to-Consumer Laboratory Testing Market – Scope of Report TMR’s report on the direct-to-consumer laboratory testing market in Japan studies the past as well as the current growth trends and opportunities to ... Read More

< prev 1 2 next >